°Ç±¹´ëÇб³º´¿ø ´ëÇѺÎÁ¤¸ÆÇÐȸ Á¦ 4Â÷ °³¿øÀÇ ¹× Àü°øÀǸ¦ À§ÇÑ ºÎÁ¤¸Æ ¿¬¼ö°Á : 2019-10-31±³À°ÀÏÀÚ : 2019-10-31
±³À°Àå¼Ò : °Ç±¹´ëÇб³º´¿ø ÁöÇÏ3Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
Á¦ 4Â÷ °³¿øÀÇ ¹× Àü°øÀǸ¦ À§ÇÑ ºÎÁ¤¸Æ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺÎÁ¤¸ÆÇÐȸ
´ã´çÀÚ : ÀüÇѺ°
¿¬¶ôó : 02-318-5416
À̸ÞÀÏ :
khrs4@k-hrs.org ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ÈäºÎ¿Ü°ú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 2 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-31 ÁöÇÏ3Ãþ´ë°´ç 19:00~19:20 Burden of Atrial Fibrillation and Stroke in Korea ±ÇâÈñ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 10-31 ÁöÇÏ3Ãþ´ë°´ç 19:20~19:40 Stroke Risk Assessment in AF with Importance of Individual Risk Factors ÃÖ¿µ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-31 ÁöÇÏ3Ãþ´ë°´ç 19:40~20:00 Non Pharmacological Management of Atrial Fibrillation ȲÀ¯¹Ì(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-31 ÁöÇÏ3Ãþ´ë°´ç 20:00~20:20 Implication of Subclinical Atrial Fibrillation on Stroke and Heart Failure ¹Úȯö(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10-31 ÁöÇÏ3Ãþ´ë°´ç 20:20~20:40 Oral anticoagulation therapy in Renal Insufficiency, Various Liver Function and Malignancy ÀÌÁ¤¸í(°æÈñÀÇ´ë)
±³À°½Ã°£ 10-31 ÁöÇÏ3Ãþ´ë°´ç 20:40~21:00 Oral anticoagulation therapy in Elderly, low body weight, and Periprocedural period ¹ÚÁø±Ô(ÇѾçÀÇ´ë)